BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30820912)

  • 21. Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non-small cell lung cancer.
    Mohiuddin K; Haneuse S; Sofer T; Gill R; Jaklitsch MT; Colson YL; Wee J; Bueno R; Mentzer SJ; Sugarbaker DJ; Swanson SJ
    J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1169-75; discussion 1175-7. PubMed ID: 24507406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of pleural recurrence after percutaneous transthoracic needle biopsy in stage I non-small-cell lung cancer.
    Ahn SY; Yoon SH; Yang BR; Kim YT; Park CM; Goo JM
    Eur Radiol; 2019 Jan; 29(1):270-278. PubMed ID: 29948086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of blood and lymphatic vessel invasion in pathological stage IA lung adenocarcinoma in the 8th edition of the TNM classification.
    Samejima J; Yokose T; Ito H; Nakayama H; Nagashima T; Suzuki M; Hamanaka R; Yamada K; Masuda M
    Lung Cancer; 2019 Nov; 137():144-148. PubMed ID: 31593845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Most peripheral, node-negative, non-small-cell lung cancers have low proliferative rates and no intratumoral and peritumoral blood and lymphatic vessel invasion. Rationale for treatment with wedge resection alone.
    Macchiarini P; Fontanini G; Hardin JM; Pingitore R; Angeletti CA
    J Thorac Cardiovasc Surg; 1992 Oct; 104(4):892-9. PubMed ID: 1328770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of lymphovascular invasion for patients with stage I non-small cell lung cancer.
    Hanagiri T; Takenaka M; Oka S; Shigematsu Y; Nagata Y; Shimokawa H; Uramoto H; Yamada S; Tanaka F
    Eur Surg Res; 2011; 47(4):211-7. PubMed ID: 22025080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.
    Miyoshi K; Moriyama S; Kunitomo T; Nawa S
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):429-34. PubMed ID: 19185165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.
    Nentwich MF; Bohn BA; Uzunoglu FG; Reeh M; Quaas A; Grob TJ; Perez D; Kutup A; Bockhorn M; Izbicki JR; Vashist YK
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):781-7. PubMed ID: 23778087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.
    Oven Ustaalioglu BB; Unal OU; Turan N; Bilici A; Kaya S; Eren T; Ulas A; Inal A; Berk V; Demirci U; Alici S; Bal O; Benekli M; Gumus M
    Asian Pac J Cancer Prev; 2013; 14(11):6287-92. PubMed ID: 24377519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence and Risk Factors for Relapse in Patients with Non-Small Cell Lung Cancer Treated by Surgery with Curative Intent.
    Cruz C; Afonso M; Oliveiros B; Pêgo A
    Oncology; 2017; 92(6):347-352. PubMed ID: 28278499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wedge resection and radiofrequency ablation for stage I nonsmall cell lung cancer.
    Ambrogi MC; Fanucchi O; Dini P; Melfi F; Davini F; Lucchi M; Massimetti G; Mussi A
    Eur Respir J; 2015 Apr; 45(4):1089-97. PubMed ID: 25700387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Recurrence Patterns After Wedge Resection for Early Stage Lung Cancer: Rationale for Radiologic Follow-Up.
    Billè A; Ahmad U; Woo KM; Suzuki K; Adusumilli P; Huang J; Jones DR; Rizk NP
    Ann Thorac Surg; 2016 Oct; 102(4):1067-73. PubMed ID: 27345095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival.
    Bréchot JM; Chevret S; Charpentier MC; Appere de Vecchi C; Capron F; Prudent J; Rochemaure J; Chastang C
    Cancer; 1996 Nov; 78(10):2111-8. PubMed ID: 8918404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer. A potential risk of limited resection.
    Ichinose Y; Yano T; Yokoyama H; Inoue T; Asoh H; Katsuda Y
    J Thorac Cardiovasc Surg; 1994 Oct; 108(4):684-6. PubMed ID: 7934103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchial resection margin length and clinical outcome in non-small cell lung cancer.
    Tomaszek SC; Kim Y; Cassivi SD; Jensen MR; Shen KH; Nichols FC; Deschamps C; Wigle DA
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1151-6. PubMed ID: 21450488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Margin Distance Does Not Influence Recurrence and Survival After Wedge Resection for Lung Cancer.
    Maurizi G; D'Andrilli A; Ciccone AM; Ibrahim M; Andreetti C; Tierno S; Poggi C; Menna C; Venuta F; Rendina EA
    Ann Thorac Surg; 2015 Sep; 100(3):918-24; discussion 924-5. PubMed ID: 26209486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of visceral pleural invasion in resected non-small cell lung cancer diagnosed by using a jet stream of saline solution.
    Maruyama R; Shoji F; Okamoto T; Miyamoto T; Miyake T; Nakamura T; Ikeda J; Asoh H; Yamaguchi M; Yoshino I; Ichinose Y
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1587-92. PubMed ID: 15173711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early recurrence after surgical resection in patients with pathological stage I non-small cell lung cancer.
    Kawachi R; Tsukada H; Nakazato Y; Takei H; Furuyashiki G; Koshi-ishi Y; Goya T
    Thorac Cardiovasc Surg; 2009 Dec; 57(8):472-5. PubMed ID: 20013621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local failure in resected N1 lung cancer: implications for adjuvant therapy.
    Higgins KA; Chino JP; Berry M; Ready N; Boyd J; Yoo DS; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):727-33. PubMed ID: 22208965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.
    Harpole DH; Herndon JE; Young WG; Wolfe WG; Sabiston DC
    Cancer; 1995 Sep; 76(5):787-96. PubMed ID: 8625181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive intraoperative pleural lavage cytology is a predictive marker of disease recurrence in stage I lung adenocarcinoma.
    Yanagawa N; Shiono S; Abiko M; Abe M; Watanabe K; Watanabe I; Uematsu M; Ogata SY; Sato T; Tamura G
    Interact Cardiovasc Thorac Surg; 2014 May; 18(5):621-5. PubMed ID: 24532312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.